ALXO · Alx Oncology Holdings Inc · Share Buybacks
$1.04
-0.04 (-3.70%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Market Cap
$143.81M
Shares
138.28M
Volume · Nov 13
673.49K
Avg daily vol (3M)
1.15M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| — | — | $119,100,000 | — | — | 10-K , filed 2026-03-09 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2018-12-31 | $6,000 | 10-K, filed 2021-03-18 |
Key facts
CIK
1810182
CUSIP
00166B105
13F (30d)
77 filings
63 filers
Visit website
Investor relations